Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor Nurcombe

Showing results (51-60 of 98) with videos related to

Pageof 10
Sort By:
Stem Cells Translational Medicine|October 28, 2017
Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative MedicineRebekah M Samsonraj, Michael Raghunath, Victor Nurcombe, et al.
Journal of Cellular Biochemistry|September 25, 2009
Purification and characterization of heparan sulfate from human primary osteoblastsSadasivam Murali, Kerry J Manton, Vinalia Tjong, et al.
Angiogenesis|May 20, 2018
Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphateSelina Poon, Xiaohua Lu, Raymond A A Smith, et al.
Stem Cells and Development|May 25, 2007
Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptorsKee Woei Ng, Tobias Speicher, Christian Dombrowski, et al.
Genesis (New York, N.Y. : 2000)|November 5, 2003
Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial-derived tissuesIan D Tonks, Victor Nurcombe, Carol Paterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survivalElsa Vanhecke, Eric Adriaenssens, Stéphanie Verbeke, et al.
Molecular Cancer|July 24, 2015
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapyLing Ling, Si Kee Tan, Ting Hwee Goh, et al.
Cancer Research|January 18, 2008
Nerve growth factor is a potential therapeutic target in breast cancerEric Adriaenssens, Elsa Vanhecke, Pasquine Saule, et al.
Stem Cells Translational Medicine|February 17, 2017
Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor-2 TransportDrew M Titmarsh, Clarissa L L Tan, Nick R Glass, et al.
Tissue Engineering. Part A|December 1, 2016
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering ApplicationsBethanie I Ayerst, Raymond A A Smith, Victor Nurcombe, et al.
Pageof 10

Showing results (51-60 of 98) with videos related to

Sort By:
Pageof 10
Stem Cells Translational Medicine|October 28, 2017
Concise Review: Multifaceted Characterization of Human Mesenchymal Stem Cells for Use in Regenerative MedicineRebekah M Samsonraj, Michael Raghunath, Victor Nurcombe, et al.
Journal of Cellular Biochemistry|September 25, 2009
Purification and characterization of heparan sulfate from human primary osteoblastsSadasivam Murali, Kerry J Manton, Vinalia Tjong, et al.
Angiogenesis|May 20, 2018
Improved recovery from limb ischaemia by delivery of an affinity-isolated heparan sulphateSelina Poon, Xiaohua Lu, Raymond A A Smith, et al.
Stem Cells and Development|May 25, 2007
Osteogenic differentiation of murine embryonic stem cells is mediated by fibroblast growth factor receptorsKee Woei Ng, Tobias Speicher, Christian Dombrowski, et al.
Genesis (New York, N.Y. : 2000)|November 5, 2003
Tyrosinase-Cre mice for tissue-specific gene ablation in neural crest and neuroepithelial-derived tissuesIan D Tonks, Victor Nurcombe, Carol Paterson, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2011
Brain-derived neurotrophic factor and neurotrophin-4/5 are expressed in breast cancer and can be targeted to inhibit tumor cell survivalElsa Vanhecke, Eric Adriaenssens, Stéphanie Verbeke, et al.
Molecular Cancer|July 24, 2015
Targeting the heparin-binding domain of fibroblast growth factor receptor 1 as a potential cancer therapyLing Ling, Si Kee Tan, Ting Hwee Goh, et al.
Cancer Research|January 18, 2008
Nerve growth factor is a potential therapeutic target in breast cancerEric Adriaenssens, Elsa Vanhecke, Pasquine Saule, et al.
Stem Cells Translational Medicine|February 17, 2017
Microfluidic Screening Reveals Heparan Sulfate Enhances Human Mesenchymal Stem Cell Growth by Modulating Fibroblast Growth Factor-2 TransportDrew M Titmarsh, Clarissa L L Tan, Nick R Glass, et al.
Tissue Engineering. Part A|December 1, 2016
Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering ApplicationsBethanie I Ayerst, Raymond A A Smith, Victor Nurcombe, et al.
Pageof 10